mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |